SCHEMBL15745697

SCHEMBL15745697

CCCCn1nc(C(F)(F)F)cc1O[C@@H]1CCN(c2ccc(C(F)(F)F)cn2)C[C@@H]1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCD O00767 1/20 0.40
HRH3 Q9Y5N1 1/20 0.39
HPGD P15428 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
GPR119 Q8TDV5 1/20 0.38
KDM4E B2RXH2 1/20 0.38
ABL1 P00519 1/20 0.38
LMNA P02545 1/20 0.38
CHRM2 P08172 1/20 0.37
CHRM5 P08912 1/20 0.37
CHRM1 P11229 1/20 0.37
CHRM3 P20309 1/20 0.37
DRD2 P14416 1/20 0.37
DRD3 P35462 1/20 0.37
TRPV1 Q8NER1 5/20 0.37
CA12 O43570 4/20 0.37
CA1 P00915 4/20 0.37
CA2 P00918 4/20 0.37
CA4 P22748 4/20 0.37
CA7 P43166 4/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15745701 1.00 SCD (0.40) SCDHRH3HPGDSMN1; SMN2GPR119
SCHEMBL756547 0.87 HRH3 (0.44) HRH3HPGDSMN1; SMN2GPR119KDM4E
SCHEMBL15745708 0.86 DPP4 (0.36) SCDHRH3HPGDSMN1; SMN2GPR119
SCHEMBL15745704 0.85 HRH3 (0.40) SCDHRH3HPGDSMN1; SMN2GPR119
SCHEMBL15745707 0.85 HRH3 (0.40) SCDHRH3HPGDSMN1; SMN2GPR119
SCHEMBL15745700 0.85 HRH3 (0.40) SCDHRH3HPGDSMN1; SMN2GPR119
SCHEMBL12371110 0.84 HCRTR1 (0.42) HRH3HPGDSMN1; SMN2GPR119KDM4E
SCHEMBL12371131 0.84 HCRTR1 (0.42) HRH3HPGDSMN1; SMN2GPR119KDM4E
SCHEMBL15745703 0.82 HRH3 (0.45) HRH3HPGDSMN1; SMN2GPR119KDM4E
SCHEMBL15745699 0.80 NR1H2 (0.43) SCDHRH3GPR119KDM4EABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140148477-A1 ANIMAL ECTOPARASITE-CONTROLLING AGENT AND METHOD FOR PREVENTING OR TREATING INFECTION IN ANIMALS CAUSED BY PARASITES BY USING THE CONTROLLING AGENT OTSUKA AGRITECHNO CO., LTD. (JP) 2014-05-29 US disclosed
US-20140148477-A1 ANIMAL ECTOPARASITE-CONTROLLING AGENT AND METHOD FOR PREVENTING OR TREATING INFECTION IN ANIMALS CAUSED BY PARASITES BY USING THE CONTROLLING AGENT OTSUKA AGRITECHNO CO., LTD. (JP) 2014-05-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140148477-A1 ANIMAL ECTOPARASITE-CONTROLLING AGENT AND METHOD FOR PREVENTING OR TREATING INFECTION IN ANIMALS CAUSED BY PARASITES BY USING THE CONTROLLING AGENT PIR, ITPA, CAT SCD 4832/4885HRH3 462/4885HPGD 3038/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.